David Stamler is the founder of Alterity Therapeutics. Alterity Therapeutics has raised $40M in total funding.
David Stamler is the Chief Executive Officer of Alterity Therapeutics, a role he has held since January 2021. He leads the company's clinical development and regulatory strategy, particularly for its lead program ATH434 for multiple system atrophy (MSA).
Full founder directory · Investor directory · Company funding database · Fundraising library